CH INV FIN GP(01226)

Search documents
中国投融资(01226) - 致非登记股东函件 – 通知信函
2024-12-11 08:39
CHINA INVESTMENT AND FINANCE GROUP LIMITED 中 國 投 融 資 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) (Stock Code 股份代號: 1226) NOTIFICATION LETTER 通知信函 Dear Non-registered Shareholder(s)(Note 1) , 12 December 2024 The following document(s) of China Investment and Finance Group Limited (the "Company") has/have been prepared in English and Chinese and is/are available on the websites of the Company at www.chnif.com.hk and The Stock Exchange of Hong Kong Limited at www.hk ...
中国投融资(01226) - 致登记股东函件 – 通知信函及回条
2024-12-11 08:38
CHINA INVESTMENT AND FINANCE GROUP LIMITED 中 國 投 融 資 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) (Stock Code 股份代號: 1226) NOTIFICATION LETTER 通知信函 Dear Registered Shareholder(s), 12 December 2024 The following document(s) of China Investment and Finance Group Limited (the "Company") has/have been prepared in English and Chinese and is/are available on the websites of the Company at www.chnif.com.hk and The Stock Exchange of Hong Kong Limited at www.hkexnews.hk (co ...
中国投融资(01226) - 2025 - 中期财报
2024-12-11 08:36
Financial Performance - For the six months ended September 30, 2024, the Group recorded gross proceeds from the disposal of securities of approximately HK$11.0 million, down from approximately HK$15.9 million for the same period in 2023, representing a decrease of about 30.6%[6] - Revenue increased from approximately HK$2.7 million for the six months ended September 30, 2023, to approximately HK$3.3 million for the current period, reflecting an increase of approximately 24.4%[6] - Loss attributable to owners decreased from approximately HK$27.7 million for the six months ended September 30, 2023, to approximately HK$7.0 million for the current period[6] - The Group reported a net realized loss on disposal of equity instruments of HK$675,000, compared to HK$4,958,000 in the previous year, indicating an improvement[98] - The Group reported a loss attributable to shareholders of approximately HK$6,966,000 for the six months ended September 30, 2024, compared to a loss of approximately HK$27,695,000 in 2023, indicating a significant improvement[117] Asset Management - The unaudited consolidated net assets of the Group as of September 30, 2024, amounted to approximately HK$151.9 million, down from approximately HK$158.9 million as of March 31, 2024[6] - The net asset value per share was approximately HK$0.37 as of September 30, 2024, compared to approximately HK$0.39 as of March 31, 2024[7] - The Group's investment portfolio value is approximately HK$151.8 million, primarily consisting of unlisted equity securities, unlisted debt securities, and listed equity securities in Hong Kong and China[12] - The Group's cash and cash equivalents decreased to approximately HK$1.0 million as of September 30, 2024, compared to approximately HK$7.1 million as of March 31, 2024[72] - The Group's gearing ratio increased to 4.5% as of September 30, 2024, from 3.9% as of March 31, 2024, indicating a slight increase in leverage[72] Investment Strategy - The Group aims to manage its investment portfolio prudently amidst high geopolitical risks and uncertainties in the global market[63] - The Group will continue to explore investment opportunities that offer outstanding returns under acceptable risk levels[64] - Minerva Group recognizes the potential in the healthcare sector and will actively pursue investments aligned with its strategic objectives[18] - The Group's investments include HK$98.6 million in listed equities, HK$46.9 million in debt investments, and HK$6.3 million in direct investments in unlisted equities[10] - The Group's loss on listed investments for the period was approximately HK$6.3 million, including net realised and unrealised losses[52] Operational Insights - The Group's operations are solely based in Hong Kong, with all revenue derived from this region[111] - The Group's activities are primarily focused on investment holding, with no significant changes in accounting policies reported for the current period[110] - The Group retained eleven employees as of September 30, 2024, consistent with the previous year[74] - Total staff costs for the six months ended September 30, 2024, were approximately HK$0.2 million, a decrease from approximately HK$0.5 million in the same period of 2023[74] - The Group did not have any significant acquisitions or disposals of subsidiaries during the six months ended September 30, 2024[72] Governance and Compliance - The Company confirmed compliance with the public float requirement of the Listing Rules for the six months ended 30 September 2024[87] - The Company has complied with the Code on Corporate Governance Practices throughout the six months ended 30 September 2024, with deviations from Provision C.2.1[88] - The roles of the Chairman and the Chief Executive Officer are currently being separated, with the Board in the process of finding an appropriate person to fill these positions[89] - Related party transactions were conducted on normal commercial terms during the six months ended September 30, 2024 and 2023[135] - The financial statements for the six months ended 30 September 2024 are unaudited[137] Future Outlook - The management believes that revenue growth and value creation from investments in Minerva Group are expected in the coming years[19] - WLS Holdings Limited anticipates that geopolitical tensions and the effects of monetary tightening will continue to impact Hong Kong's economic growth in 2024[20] - WLS Group will maintain its focus on scaffolding, fitting out, and auxiliary services for construction, as well as money lending and securities investment[20] - WLS Group aims to explore suitable investment opportunities to diversify its business horizons and strengthen overall development[29] - The company plans to continue expanding into corporate and individual loans through its wholly-owned subsidiaries, E Cash Fintech Limited and E Finance Limited[15]
中国投融资(01226) - 2025 - 中期业绩
2024-11-28 10:05
Financial Performance - Total revenue for the six months ended September 30, 2024, was HKD 3,318,000, an increase of 24.4% compared to HKD 2,668,000 for the same period in 2023[1] - The net loss attributable to shareholders for the period was HKD 6,966,000, a significant improvement from a net loss of HKD 27,695,000 in the previous year[1] - The company reported a realized loss of HKD 675,000 from the sale of equity instruments measured at fair value through profit or loss, compared to a loss of HKD 4,958,000 in the prior year[1] - Revenue increased from approximately HKD 2,700,000 for the six months ended September 30, 2023, to approximately HKD 3,300,000 for the same period in 2024, representing a growth of approximately 24.4%[43] - Loss attributable to owners decreased from approximately HKD 27,700,000 for the six months ended September 30, 2023, to approximately HKD 7,000,000 for the same period in 2024[43] Assets and Liabilities - The total assets as of September 30, 2024, were HKD 151,896,000, a decrease from HKD 158,862,000 as of March 31, 2024[8] - The net asset value per share decreased to HKD 0.37 from HKD 0.39 in the previous period[11] - The company's cash and cash equivalents amount to approximately HKD 1,000,000 as of September 30, 2024, a decrease from approximately HKD 7,100,000 as of March 31, 2024[74] - The group's debt-to-equity ratio stands at 4.5% as of September 30, 2024, compared to 3.9% as of March 31, 2024, indicating a slight increase[76] - The group has no significant contingent liabilities as of September 30, 2024[79] Investments - The fair value of listed equity investments in Hong Kong as of September 30, 2024, is HKD 98,667,000, down from HKD 104,196,000 as of March 31, 2024[30] - The total fair value of debt investments as of September 30, 2024, is HKD 13,271,000, with a significant investment in China 333 Media Group Limited valued at HKD 13,271,000[30] - The group's investment portfolio value was approximately HKD 151,800,000, primarily consisting of unlisted equity securities, unlisted debt securities, and listed equity securities[45] - Significant investments included equity investments in Ying Group Holdings Limited (fair value HKD 15.4 million, 9.7% of total assets) and Hui Long Holdings Limited (fair value HKD 14.3 million, 9.0% of total assets)[47] - The group has approximately HKD 98,600,000 in highly liquid listed securities as of September 30, 2024[74] Operating Expenses - Operating expenses for the period included total employee costs of HKD 208,000, down from HKD 476,000 in the previous year[25] - The company incurred management fees of HKD 360,000 for the six months ended September 30, 2024, consistent with the previous year[37] Dividends and Shareholder Returns - The company did not declare any dividends for the six months ended September 30, 2024, consistent with the previous year[27] - The company has not proposed any interim dividend for the six months ending September 30, 2024, compared to no dividend in the same period of 2023[71] Business Strategy and Future Outlook - The group plans to continue expanding its lending business through its wholly-owned subsidiaries, focusing on risk management strategies to balance long-term risks and returns[50] - The group recognizes the potential of the healthcare sector and aims to explore investment opportunities within this industry to create sustainable returns[51] - 汇隆集团计划在2024/2025年度检讨资产结构和业务策略,以应对经济不稳定性[54] - 汇隆集团将继续专注于高利润率及具发展潜力的业务分部,如借贷业务[54] - 汇隆集团将积极探索适宜的投资机会,以推动业务整体发展[55] Management and Governance - The board is actively seeking suitable candidates to fill the vacancies of the chairman and CEO roles, which should be separated as per governance guidelines[81] Miscellaneous - The company has not engaged in any significant acquisitions or disposals of subsidiaries during the six months ending September 30, 2024[75] - The company has no specific plans for significant investments or capital assets as of the announcement date[70] - The company has not entered into any foreign currency hedging contracts during the period[78]
中国投融资(01226) - 董事会会议通告
2024-11-13 08:31
(於開曼群島註冊成立之有限公司) (股份代號:1226) 董事會會議通告 中國投融資集團有限公司(「本公司」)董事會(「董事會」)茲通告謹定於二零二四 年十一月二十八日(星期四)召開董事會會議,藉以(其中包括)批准本公司及其 附屬公司截至二零二四年九月三十日止六個月中期業績及考慮派發中期股息(如 有)。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 CHINA INVESTMENT AND FINANCE GROUP LIMITED 中國投融資集團有限公司 承董事會命 中國投融資集團有限公司 執行董事 陳昌義 香港,二零二四年十一月十三日 於本公佈日期,董事會由執行董事陳昌義先生;非執行董事吳祺先生及方安石先生; 以及獨立非執行董事陸東全先生、劉曉茵女士及韓亮先生組成。 ...
中国投融资(01226) - 资產净值
2024-11-13 08:31
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責, 對其準確 性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 於二零二四年十月三十一日,本公司每股股份之未經審核綜合資產淨值約為 0.39港元。 CHINA INVESTMENT AND FINANCE GROUP LIMITED 於本公佈日期,董事會由執行董事陳昌義先生,非執行董事吳祺先生及方安石先 生,以及獨立非執行董事陸東全先生、劉 曉茵女士 及韓亮先生 組成。 中國投融資集團有限公 司 香港,二零二四年十一月十三日 (於開曼群島註冊成立之有限公司) (股份代號:1226) 資產淨值 ...
中国投融资(01226) - 2024 - 年度财报
2024-07-29 08:30
Financial Performance - The Group's net loss decreased from approximately HK$41.2 million for the year ended March 31, 2023, to approximately HK$37.8 million for the year ended March 31, 2024[14]. - Interest income increased from approximately HK$3.5 million last year to approximately HK$5.1 million this year, contributing to the reduction in net loss[14]. - Revenue increased by approximately 48.1% to approximately HK$5.3 million from approximately HK$3.6 million last year[17]. - The audited consolidated net assets of the Group as of March 31, 2024, amounted to approximately HK$158.9 million, down from approximately HK$196.6 million in 2023[17]. - The net asset per share decreased to approximately HK$0.39 from approximately HK$0.48 in the previous year[17]. - The Group recorded a net loss on listed investments of approximately HK$32.2 million for the year, compared to a net loss of approximately HK$30.7 million last year[14]. - Impairment loss related to expected credit loss assessment increased to approximately HK$2.7 million from approximately HK$1.2 million last year[14]. - Administrative expenses decreased from approximately HK$9.9 million last year to approximately HK$7.1 million this year[14]. - The Group's cash and cash equivalents have decreased to HK$7,112,000 from HK$27,585,000, indicating a decline of approximately 74.2%[105]. - Total equity decreased to HK$158,862,000 in 2024 from HK$196,631,000 in 2023, representing a decline of approximately 19.2%[124]. Investment Portfolio - The Group's investment portfolio was valued at approximately HK$155.3 million as of March 31, 2024, comprising listed and unlisted securities and bonds[24]. - Significant investments include equity investments in WLS Holdings Limited (fair value HK$13.2 million, 7.8% of total assets), Minerva Group Holding Limited (fair value HK$15.6 million, 9.3% of total assets), and bonds investments in Hao Wen Holdings Limited (fair value HK$17.2 million, 10.2% of total assets)[35]. - The Group's investment portfolio as of March 31, 2024, is valued at approximately HK$155.3 million, comprising unlisted securities, listed securities, and bonds investments in Hong Kong and China[76]. - The Group plans to invest in certain unlisted securities, listed securities, and fixed income products to further diversify market risk[112]. - The Group is exploring the adoption of mixed scaffolds and metal scaffolds in response to market demand, indicating a strategic shift in business direction[75]. Economic Outlook - The Hong Kong economy is expected to grow more slowly than previously anticipated in 2023 and 2024 due to uncertainties in China's economy and high interest rates, leading to a decline in the Hong Kong property market[37]. - The Hong Kong Government revised its economic growth forecast for 2023 down to 3.2% from a previous estimate of 4% to 5%[51]. - For 2024, Minerva maintains an optimistic outlook for the Hong Kong economy, anticipating a gradual recovery as global economic stability is achieved[52]. - The Directors anticipate that the global market will continue to face challenges and uncertainties, particularly in the context of high inflation and potential recession[111]. Corporate Governance - The Group's compliance with the Corporate Governance Code was maintained throughout the year, with some deviations noted[170]. - The audit committee reviewed the consolidated results for the year ended March 31, 2024, focusing on accounting principles and practices[153]. - The Group has adhered to the corporate governance code as per the Stock Exchange listing rules, with a noted deviation from rule C.2.1[195]. - The audit committee consists of three independent non-executive directors: Mr. Han Liang, Mr. Luk Simon, and Ms. Liu Xiaoyin[197]. Human Resources - The total number of employees remains stable at 17, with a turnover rate of 0%[132]. - The employee distribution includes 11 males and 6 females, with all employees being full-time[133]. - The company maintains a zero employee turnover rate across all categories, including gender and employment type[134]. - The recruitment and promotion processes are conducted fairly and openly, ensuring compliance with statutory requirements[136]. - The company emphasizes equal opportunity and diversity in its employment policy, with a commitment to a respectful workplace[138]. - The Group has implemented a staff training management system to enhance employee development and competitiveness[192]. - The Group has encouraged participation in external programs for continuous professional development and skillset enhancement[193]. Strategic Direction - WLS is reviewing its asset structure and business strategies to consolidate resources and adapt to future uncertainties, while adhering to strict cost control policies[40]. - WLS plans to actively explore suitable investment opportunities to diversify its business and align with the Hong Kong Government's strategic development plans for property construction and infrastructure investment[41]. - The scaffolding industry faces challenges due to rising labor costs, declining productivity, and an aging workforce, leading to a lack of confidence in its future prospects[32]. - The shift towards metal scaffolding over bamboo scaffolding is expected to dominate the market due to its durability and reduced training time for workers[39]. Financial Health - The Group's amounts due to brokers increased to approximately HK$6.2 million as of March 31, 2024, compared to approximately HK$5.0 million in 2023[114]. - The debt-to-equity ratio is 3.9%, indicating a very low leverage level compared to 2.6% in 2023[119]. - The total gross amount of debt investments measured at amortised cost is approximately HK$54,468,000, with an accumulated impairment provision of approximately HK$9,651,000 as of March 31, 2024[90]. - The Group held listed securities valued at approximately HK$104.2 million as of March 31, 2024, down from approximately HK$132.5 million in 2023, which is around 16.8 times the amounts due to brokers[114]. - The unrealized loss for the year was approximately HK$43.9 million, primarily attributed to specific stocks, with no other stocks generating unrealized gains over HK$3.0 million[110]. Losses and Dividends - As of March 31, 2024, the Group reported accumulated losses of HK$927,087,000, an increase from HK$889,318,000 as of March 31, 2023, reflecting a loss of HK$37,769,000 for the year[107]. - The Company does not recommend a payment of final dividend for the year[113]. - Total staff costs for the year were approximately HK$0.7 million, significantly reduced from approximately HK$4.2 million in 2023, primarily due to the absence of share-based payments this year[163].
中国投融资(01226) - 2024 - 年度业绩
2024-06-28 13:26
Financial Performance - Total revenue for the year ended March 31, 2024, was HKD 5,318,000, an increase of 48% from HKD 3,592,000 in the previous year[5] - The total proceeds from the sale of listed securities amounted to HKD 29,770,000, a significant decrease of 83% compared to HKD 177,729,000 in the prior year[5] - The net loss before tax for the year was HKD 37,769,000, an improvement of 8% from a loss of HKD 41,152,000 in the previous year[5] - Basic and diluted loss per share for the year was HKD 9.15, compared to HKD 10.92 in the previous year, indicating a reduction in loss per share[5] - The group recorded total proceeds from the sale of securities of approximately HKD 29.8 million, a decrease of about 83.2% compared to approximately HKD 177.7 million last year[32] - The group achieved revenue of approximately HKD 5.3 million, an increase of about 48.1% from approximately HKD 3.6 million last year[32] - The net loss attributable to the company's owners was approximately HKD 37.8 million, down from approximately HKD 41.2 million last year[32] Assets and Equity - Non-current assets totaled HKD 39,121,000, an increase of 64% from HKD 23,834,000 in the previous year[7] - Current assets decreased to HKD 129,166,000 from HKD 180,661,000, reflecting a decline of 29%[7] - Cash and cash equivalents dropped significantly to HKD 7,112,000 from HKD 27,585,000, a decrease of 74%[7] - Total equity decreased to HKD 158,862,000 from HKD 196,631,000, a decline of 19%[7] - The group's audited net asset value as of March 31, 2024, was approximately HKD 158.9 million, compared to approximately HKD 196.6 million last year[32] - The net asset value per share was HKD 0.39 as of March 31, 2024, down from HKD 0.48 in 2023[61] Investments - As of March 31, 2024, the group's investment portfolio is valued at approximately HKD 155.3 million, comprising direct investments in unlisted equity securities, listed company bonds, and unlisted company bonds[35] - The group's significant investments include equity investments in Huilong Holdings Limited (HKD 13.2 million, 7.8% of total assets) and Ying Group Holdings Limited (HKD 15.6 million, 9.3% of total assets) as well as bond investments in Haowen Holdings Limited (HKD 17.2 million, 10.2% of total assets)[36] - The group incurred a loss of approximately HKD 32.2 million from listed investments, with realized losses of approximately HKD 45.7 million and unrealized gains of approximately HKD 13.2 million[49] Operational Highlights - The group’s main business remains investment holding and trading of securities, with no new strategic initiatives or product developments mentioned in the report[9] - The group did not declare or recommend any dividends for the year ended March 31, 2024, consistent with the previous year[26] - The group did not engage in any significant acquisitions or disposals of subsidiaries, associates, or joint ventures during the fiscal year ending March 31, 2024[63] - The group employed 11 staff members as of March 31, 2024, with total employee costs approximately HKD 700,000, a significant decrease from HKD 4,200,000 in 2023[64] Financial Management and Strategy - The company has not applied any new accounting standards that are not yet effective, indicating stability in accounting practices for the foreseeable future[16] - The group emphasizes strict cost control policies and rapid adjustments to business strategies in response to market changes to enhance shareholder returns[38] - Ying Group is reassessing its financial strategies to mitigate potential impacts from changing interest rates and global economic conditions[41] Market Outlook - For 2024, Ying Group maintains an optimistic outlook for the Hong Kong economy, anticipating gradual recovery as global economic stability is expected to improve[44] - The group plans to closely monitor the performance of Huilong and Ying Group, adjusting investment strategies as necessary to respond to market dynamics[40][44] - Huilong is reviewing its asset structure and business strategy to adapt to the uncertain economic environment in Hong Kong[38] Compliance and Governance - The company complied with the corporate governance code but deviated from the requirement that the roles of chairman and CEO should be separate[69] - The audit committee reviewed the group's consolidated performance for the year ending March 31, 2024, including accounting principles and risk management[70] - The audit committee consists of three independent non-executive directors[71] - The preliminary performance data for the year ending March 31, 2024, was confirmed by the group's auditor, but no assurance opinion was issued[72] - The annual report for 2023/2024 will be sent to shareholders and published on the stock exchange and the company's website[74]
中国投融资(01226) - 2024 - 中期财报
2023-12-14 10:04
Financial Performance - For the six months ended 30 September 2023, the company reported a net loss of HK$27,695,000 compared to a profit of HK$12,431,000 in the same period last year[4]. - For the six months ended 30 September 2023, the Group recorded a loss attributable to equity holders of approximately HK$27.7 million, compared to a profit of approximately HK$12.4 million for the same period in 2022[41]. - Basic loss per share for the six months ended 30 September 2023 was HK$6.71, compared to earnings of HK$3.65 per share for the same period in 2022[43]. - The Group reported a loss on listed investments of approximately HK$26.7 million, which included a net realized loss of approximately HK$5.0 million and a net unrealized loss of approximately HK$21.9 million[102]. - The Group's cash and cash equivalents decreased to approximately HK$6.2 million as of 30 September 2023, compared to approximately HK$27.6 million as of 31 March 2023[110]. Equity and Assets - Total equity decreased to HK$168,936,000 as of 30 September 2023, down from HK$196,631,000 as of 31 March 2023, representing a decline of approximately 14.1%[2]. - The net asset value per share decreased to HK$0.41 from HK$0.48, a decline of approximately 14.6%[2]. - The total assets as of 30 September 2023 were HK$302,869,000, down from HK$373,292,000 as of 31 March 2023, indicating a decrease of approximately 19%[2]. - The unaudited consolidated net assets of the Group as at 30 September 2023 amounted to approximately HK$168.9 million, a decrease from approximately HK$196.6 million as of 31 March 2023[41]. - The investment portfolio's value was approximately HK$160.1 million, primarily consisting of unlisted equity securities, unlisted debt securities, and listed equity securities[53]. Revenue and Income - For the six months ended 30 September 2023, the Group's revenue totaled HK$2,668,000, an increase of 36.5% compared to HK$1,953,000 for the same period in 2022[8]. - Revenue increased by approximately 36%, from HK$1.95 million for the six months ended 30 September 2022 to approximately HK$2.67 million for the same period in 2023[41]. - Dividend income from equity investments at fair value through profit or loss was HK$220,000, up 77.4% from HK$124,000 in the previous year[8]. - Interest income from debt investments increased to HK$1,626,000, representing a growth of 20.3% from HK$1,352,000 in 2022[8]. - Interest income from other receivables rose to HK$822,000, a 72.2% increase compared to HK$477,000 in the prior year[8]. Expenses and Costs - Total directors' remuneration for the period was HK$510,000, a decrease from HK$1,409,000 in the previous year[15]. - Total staff costs, excluding directors' remuneration, were HK$476,000, significantly lower than HK$3,884,000 in the same period last year[15]. - Administrative expenses for the six months ended 30 September 2023 were approximately HK$3.27 million, a decrease from HK$6.93 million in the previous year[43]. - Total employee cost for the review period was approximately HK$500,000, a significant decrease from approximately HK$3.9 million in 2022, primarily due to the absence of share-based payments during the period[152]. Investments and Strategy - The Group's investments included HK$105.9 million in listed equities and HK$6.6 million in unlisted equities as of 30 September 2023[39]. - The Group aims to expand its margin financing business by leveraging the extensive social networks of its experienced employees and new hires[93]. - The Group's investment strategy will continue to focus on the healthcare sector to seek sustainable returns amid increasing health awareness[97]. - The Group plans to explore investment opportunities in the healthcare sector to ensure sustainable returns[118]. - The Group will continue to monitor the performance of WLS and adjust its investment strategy as necessary, aligning with the Hong Kong Government's development plan[57]. Cash Flow and Financing - The company reported net cash used in operating activities of HK$21,402,000 for the period, compared to net cash generated of HK$7,092,000 in the previous year[5]. - The Group did not generate any cash from investing activities during the period[5]. - The gearing ratio increased to 3.3% as of 30 September 2023, up from 2.6% as of 31 March 2023, indicating a slight increase in leverage[110]. - The Group's margin payables related to listed investments amounted to HK$27,800,000 as of September 30, 2023, compared to HK$18,200,000 as of March 31, 2023[160]. Corporate Governance and Compliance - The Group complied with the Code on Corporate Governance Practices throughout the six months ended September 30, 2023[163]. - The Company confirmed compliance with the public float requirement of the Listing Rules for the six months ended 30 September 2023[139]. - The Group did not have any significant contingent liabilities as of 30 September 2023[138]. Market and Economic Outlook - Hong Kong is expected to continue recovering economic growth in 2023, benefiting from the rebound in inbound tourism and personal consumption[64][89]. - The U.S.-China financial tensions may prompt more mainland companies to consider listing in Hong Kong, bringing in more capital inflow[65][90]. - The Group's management emphasizes a prudent approach in managing its investment portfolio amid high geopolitical risks and market uncertainties[130].
中国投融资(01226) - 2024 - 中期业绩
2023-11-29 08:30
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 CHINA INVESTMENT AND FINANCE GROUP LIMITED 中 國 投 融 資 集 團 有 限 公 司 (於開曼群島註冊成立之有限公司) (股份代號:1226) 中期業績公佈 截至二零二三年九月三十日止六個月 中國投融資集團有限公司(「本公司」)及其附屬公司(統稱「本集團」)董事(「董事」) 會(「董事會」)欣然公佈本集團截至二零二三年九月三十日止六個月(「本期間」) 之未經審核綜合業績。 簡明綜合損益及其他全面收益表 截至二零二三年九月三十日止六個月 未經審核 截至九月三十日止六個月 二零二三年 二零二二年 附註 千港元 千港元 出售證券之所得款項總額 15,922 24,647 收益 3 2,668 1,953 出售以公平值計入損益賬之股本工具之 已變現(虧損)╱收益淨額 (4,958) 5,085 以公平值計入損益賬之股本工具之 未變現(虧損)╱收益淨額 (21,938) ...